Chi-Hang Lee, MD, MBBS, MRCP

Xiao-Ling Zhang , MD;

Than-Than Kyaing , MD;

Mark Y. Chan , MBBS;

Collateral Formation in Patients After Percutaneous Myocardial Revascularization: A Mechanism for Improvement?

Hwee Bee Wong , MSc, MD;

Drug-eluting stents (DES) have emerged as a novel technology in coronary revascularization. Ample evidence has shown that polymer-based DES effectively reduce in-stent restenosis and repeat revascularization after percutaneous coronary...

Drug-eluting stents (DES) have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Patrick W. Serruys , MD, PhD;

Muzaffer Degertekin , MD;

Pieter C. Smits , MD, PhD;

Kengo Tanabe , MD;

Willem J. van der Giessen , MD, PhD;

Ron T. van Domburg , PhD;

Incidence and Predictors of Side-Branch Compromise in Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction

Percutaneous myocardial revascularization (PMR) has emerged as a less invasive alternative to the transmyocardial revascularization (TMR), which requires thoracotomy. Initial results of PMR are encouraging with a significant proportion of...

Percutaneous myocardial...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

07/08/2014

Tiong-Cheng Yeo , MD;

Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents

Valerie Khoo ;

Liang Shen , PhD;

Vanessa Khoo ;

Germaine Loo ;

Mark Richards , MD, PT;

A study to determine the incidence and predictors of side-branch compromise in patients who underwent primary percutaneous coronary intervention for acute myocardial infarction.

A study to determine the...

07/08/2014

Journal of Invasive Cardiology

04/15/2018

Koo-Hui Chan , MD;

Joshua Loh , MD;

Hui Wen Sim , MBBS;

Siew Pang Chan , PhD;

Mark Y. Chan , MBBS;

Edgar L. Tay , MBBS;

Poay Huan Loh , MBBS, MD;

Rajiv Ananthakrishna , MD, DM;

Transcatheter Closure of Patent Ductus Arteriosus in Chinese Adults: Immediate and Long-term Results

An evaluation of the 1-year clinical outcomes of patients treated with 2.0 mm drug-coated balloon vs 2.0 mm drug-eluting stent implantation in small-caliber vessel de novo coronary artery disease.

An evaluation of the 1-year...

04/15/2018

Journal of Invasive Cardiology

08/01/2008

Alex S. Yip , MBBS, FRCP;

Wing-hing Chow , MBBS, FRCP;

Predictors of Survival After Contemporary Percutaneous Coronary Revascularization for Acute Myocardial Infarction in the Real Wo

Yim-lung Leung , MBChB, MSc;

Nim-pong Kwong , MBChB, MRCP;

On-hing Kwok , MBBS, MRCP;

Patent ductus arteriosus (PDA) is a common congenital cardiac anomaly. Depending on the size of the PDA, patients may be asymptomatic or in heart failure. Treatment is recommended because of the risk of infective endocarditis and congestive...

Patent ductus arteriosus (PDA)...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Pieter C. Smits , MD, PhD;

Willem J. van der Giessen , MD, PhD;

Pim J. de Feyter , MD, PhD;

Ron T. van Domburg , PhD;

Kengo Tanabe , MD;

Safety and Feasibility of X-Sizer-Facilitated Rescue Percutaneous Coronary Intervention: A Preliminary Experience

Angela Hoye , MB, MRCP, MD, MBChB;

Pedro A. Lemos , MD;

Patrick W. Serruys , MD, PhD;

Management strategies for ST-elevation myocardial infarction (STEMI) have undergone great evolution over the past decade. Currently, primary mechanical reperfusion is considered superior to thrombolytic therapy in achieving complete and...

Management strategies for...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Swee Guan Teo , MBBS, MD;

Antono Sutandar , MD;

Impact of Glycemic Control on Occurrence of No-Reflow and 30-Day Outcomes in Diabetic Patients Undergoing Primary Angioplasty fo

Although primary percutaneous coronary intervention (PCI) has been proven to be superior to thrombolytic therapy for the treatment of acute ST-elevation myocardial infarction (STEMI),1–3 the latter approach is still widely practiced due to...

Although primary percutaneous...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Swee Guan Teo , MBBS, MD;

Antono Sutandar , MD;

Eric Hong , MBBS;

Hwee Bee Wong , MSc, MD;

Procedural Success and 30-Day Outcomes between CYPHER‚Ñ¢ and TAXUS¬Æ Stent Implantation for the Treatment of Bifurcation Lesions ‚Äî

Primary percutaneous transluminal coronary angioplasty (PTCA) has been consistently demonstrated to be superior to thrombolytic therapy and is currently the recommended therapy for myocardial infarction (MI).1 However, no-reflow phenomenon...

Primary percutaneous...

08/01/2008

Journal of Invasive Cardiology

08/01/2008

Swee Guan Teo , MBBS, MD;

Hwee Bee Wong , MSc, MD;

Jun Jie Zhang , MD;

Chao Yang Soon , MD;

Lethal Presentations of Coronary Artery Spasm after an Event-Free
Period of Six Years following Initial Diagnosis

CYPHER™ (sirolimus-eluting stent, Cordis, Johnson and Johnson, Miami, Florida) and TAXUS® (polymer-based paclitaxel-eluting stent, Boston Scientific Corporation, Natick, Massachusetts) stents are the two drug-eluting stents (DES) currently...

CYPHER™ (sirolimus-eluting...

08/01/2008

Journal of Invasive Cardiology

Feature

08/01/2008